Form D · Other

Attivare Therapeutics, Inc.

Natick, MA · CIK 0001880794

Offering snapshot reported Dec 17, 2021 · SEC filing

Reported sold
$5.88M
Offering amount: $7.83M
Investors reported
23
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 16, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.94M$5.88MSep 1, 2021: $4,825,824.00Sep 1, 2021Dec 17, 2021: $5,876,955.00Dec 17, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$4,825,824 → $5,876,955

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 17, 2021Amendment$5,876,955$1,051,131vs Sep 1, 202123SEC filing
Sep 1, 2021Initial$4,825,824No comparisonNot reportedSEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-412051
The amount sold includes convertible debt and the securities issuable upon conversion.
Amount sold includes the conversion of debt and the securities issuable upon conversion.

Source: Form D, filed Dec 17, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Edward Doherty Executive
Jessica Mc Donough Director
Zeshan Muhammedi Director
Joaquim Trias Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:
22 Strathmore Road
Natick, MA, 01760